XML 50 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis
The following tables present information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis and their assigned levels within the valuation hierarchy as of the periods presented:
March 31, 2024
(in thousands)Level 1Level 2Level 3Total
Assets   
Cash equivalents from money market funds$13,600 $— $— $13,600 
Interest rate swaps$— $1,952 $— $1,952 
Liabilities
Interest rate swaps— 2,061 — 2,061 
Contingent consideration— — 9,739 9,739 
December 31, 2023
(in thousands)Level 1Level 2Level 3Total
Assets   
Cash equivalents from money market funds11,593 — — 11,593 
Interest rate swaps— 1,187 — 1,187 
Liabilities
Interest rate swaps— 5,357 — 5,357 
Contingent consideration$— $— $2,989 $2,989 
Schedule of Fair Value of the Level 3 Liabilities with Significant Unobservable Inputs
The following table summarizes the change in fair value of the Level 3 liabilities with significant unobservable inputs for the periods presented:
Three Months Ended
March 31,
(in thousands)
20242023
Fair value of contingent consideration, beginning of period
$2,989 $1,219 
Acquired liabilities2,750 4,706 
Cash payments
— — 
Change in fair value of contingent consideration, net(1)
4,000 (305)
Fair value of contingent consideration, end of period(2)
$9,739 $5,620 
_________________________
(1)During the three months ended March 31, 2024, the Company recorded a $4.0 million increase in the fair value of the contingent consideration, in accordance with the purchase agreement with EBI. Refer to Note 2. Summary of Significant Accounting Policies” for further information regarding this out-of-period adjustment.
(2)Recorded in Other current liabilities on the condensed consolidated balance sheets.